Search Results - "Kim, Byungkun"

Evaluation of injection-site-related adverse events with galcanezumab: a post hoc analysis of phase 3 studies in participants with migraine by Stauffer, Virginia L, Wang, Shufang, Bonner, Jo, Kim, ByungKun, Bhandari, Rohit, Day, Kathleen A, Camporeale, Angelo

“…Injection-site reactions have been reported with biologicals. In this post hoc analysis of Phase 3 studies in participants with migraine, we provide a…”
Get full text

Pooled analysis of safety and efficacy of fremanezumab in different racial and ethnic subgroups of patients with migraine by Iv, Larry Charleston, Cohen, Joshua, Ning, Xiaoping, Campos, Verena Ramirez, Barash, Steve, Lengil, Tamar, Kim, Byungkun

Get full text

200  A randomized, placebo-controlled study of galcanezumab in patients with treatment-resistant migraine: double-blind results from CONQUER by Mulleners, Wim, Kim, ByungKun, Láinez, Miguel, Lanteri-Minet, Michel, Aurora, Sheena, Nichols, Russell, Wang, Shufang, Tockhorn-Heidenreich, Antje, Pain, Andrew

“…ObjectiveCONQUER assessed galcanezumab efficacy and safety in patients with episodic or chronic migraine who had multiple migraine preventive treatment…”
Get full text

Sit-up dizziness and head-shaking dizziness may be diagnostic symptoms of vestibular migraine by Han, Byung In, Lee, HoWon, Ryu, Sanghyo, Park, Miso S, Kim, Byungkun

“…Background: Vestibular migraine (VM) frequently presents as a diagnostic challenge because objective neurological findings consistent with this entity have not…”
Get full text

OnabotulinumtoxinA for chronic migraine in Korea: 1-month postmarketing surveillance and phase 4 trial results by Kim, ByungKun, Kim, Manho, Chung, Chin-Sang, DeGryse, Ronald, Lai, Karen, Yushmanova, Irina, Lum, Arlene, Davar, Gudarz

Get full text

Unilateral arm flapping gait as a manifestation of synkinesis following recurrent strokes by Kang, Kyusik, Lee, Wong-Woo, Kwon, Ohyun, Kim, Byung

“…A 67-year old woman with a history of mitral valve replacement 11 years ago, and the development of left hemiparesis 5 years previously, was admitted to our…”
Get full text

Étude de phase III, contrôlée, randomisée, de supériorité de galcanézumab versus placebo, chez les patients atteints de migraine difficile à traiter : résultats de l’étude CONQUER by Mulleners, Wim M., Kim, Byungkun, Láinez, Miguel Ja, Lanteri-Minet, Michel, Aurora, Sheena K., Nichols, Russell M., Wang, Shufang, Tockhorn-Heidenreich, Antje, Detke, Holland C.

“…CONQUER est une étude contrôlée de phase III ayant concerné la prophylaxie des patients migraineux difficiles à traiter. Évaluer l’efficacité et la sécurité…”
Get full text